Stock Ticker

  • Loading stock data...

Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) Delivers 10,000 COVID-19 Doses in Chile As Vaccination Commences

Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in South America to commence vaccinations against the coronavirus that has so far infected over 584,545 Chileans to date. Chileans skeptical about COVID-19 vaccine The first Chilean to receive the vaccine […]

Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges

Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. The company is developing a COVID-19 vaccine in partnership with Germany-based BioNTech SE (NASDAQ:BNTX). Pfizer to deliver 50 million vaccine doses this year The pharmaceutical giant has slashed its initial […]

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commences COVID-19 Vaccine Trials In Teenagers and Children

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years. According to the trial’s lead researcher already parents have shown interest in enrolling children in the study. Pfizer and BioNTech start testing COVID-19 vaccine in kids The trial’s expansion to […]

Pfizer Inc. (NYSE:PFE) And BioNtech (NASDAQ:BNTX) Partners With Rentschler To Purify mRNA-Based COVID-19 vaccine

Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of their mRNA-based SARS-CoV-2 vaccine, BMNT1762b2. Rentschler to purify Pfizer and BioNtech’s COVID-19 vaccine drug substance The companies are conducting late-stage clinical studies of the vaccine and expect to release data […]